A pilot feasibility study to assess a new therapy addresses a critical gap in treatment options for a high-risk patient population with unique emotional needs.
A new study shows that omitting aspirin from an anti-clotting regimen can improve outcomes for people living with a heart pump by reducing hospitalizations without increasing the risk of blood clots.
A new BRAIN Initiative atlas showcases the diverse cell populations within the human hypothalamus, paving the way to discovering novel cellular targets for obesity and metabolic disease
A study led by Columbia obstetricians has shown that a new device can rapidly control postpartum hemorrhage, a major cause of severe maternal morbidity and death, in a wide range of patients.
Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers finds that the trendy obesity drug is not cost-effective at its current price.
An experimental gel developed by arthritis researchers at Columbia's College of Dental Medicine can reduce osteoarthritis in animals when injected into the joints.
A mechanism used by adult zebrafish to create new neurons in the brain is dormant in people; reawakening it might repair our brains and slow Alzheimer’s disease.
A study led by Columbia neurosurgeons has found that MRI-guided laser ablation is a viable treatment that can provide lasting seizure control for people with drug-resistant temporal lobe epilepsy.
Grants management expert Jaime Rubin, PhD, is sharing her expertise in Kosovo to help the government develop systems and programs to best support the country's researchers.
Many researchers believe that the neurodegenerative disorder gets started in the gut. Columbia research now suggests that an autoimmune reaction may be driving those early events.
Columbia researchers have identified brain circuits that, when injured, make conscious patients with acute brain injury appear unresponsive, a phenomenon known as hidden consciousness.